Show simple item record

dc.contributor.authorLyagoba, Leonie Erone
dc.date.accessioned2023-12-18T10:06:47Z
dc.date.available2023-12-18T10:06:47Z
dc.date.issued2023
dc.identifier.urihttp://hdl.handle.net/20.500.12281/17886
dc.description.abstractMajor objective of the study: To develop an in-house RNA extraction kit for extraction of high quality RNA. Specific objectives of the study: To determine the reagents required to develop the in-house RNA Extraction kit, to develop an inhouse RNA extraction kit for the extraction of high-quality RNA, and to compare the performance of the developed kit with a commercial extraction kit. Methodology: The study was at the Genomics and Molecular biology laboratory, College of Health Sciences Makerere University between April 2023, and June 2023. It was an applied experimental study aimed at developing and evaluating the extraction efficiency of an in-house SARS-CoV-2 RNA extraction kit. Reagents and samples used for the study were obtained from the Genomics and Molecular biology laboratory with permission obtained from the laboratory management. Nine nasopharyngeal swab samples for covid-19 that were stored under appropriate conditions were used for the study being randomly sampled to contain both positive and negative samples. SARS-CoV-2 RNA extraction from the 9 samples was done in two sets using two RNA extraction kits i.e., developed in-house covid-19 RNA extraction kit and the Zymo Quick Viral RNA kit which acted as the reference kit for comparison during extraction efficiency assessment. A PCR master mix was prepared using the available commercial RT-PCR kit [Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR] kit, and test run was performed using Quant Studio 7 Flex PCR-platform. Results: In this study, viral RNA was extracted from nine samples using two different kits, an in house developed kit, and the Zymo Quick Viral RNA kit. Out of the Nine samples extracted with the inhouse developed kit, seven samples tested negative for viral RNA and two tested positive. Meanwhile the same samples processed with the Zymo Quick Viral RNA kit, five samples tested negative, and four samples tested positive for SARS Cov-2 viral RNA. There were discrepancies in the results obtained that could have been due to extraction errors, contamination and even errors during preparation for the PCR. Nevertheless, the general ability of the developed kit to extract covid-19 viral RNA was evident.en_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectRNA Extractionen_US
dc.subjectCoronavirus diseaseen_US
dc.subjectCOVID 19en_US
dc.subjectSARS-COV-2en_US
dc.subjectSevere acute respiratory syndromeen_US
dc.titleDevelopment and evaluation of an in-house RNA Extraction kit for severe acute respiratory syndrome Corona Virus 2(SARS-COV-2)en_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record